Intrinsic Value of S&P & Nasdaq Contact Us

Pieris Pharmaceuticals, Inc. PIRS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
36/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Pieris Pharmaceuticals, Inc. (PIRS) has 20 known insider and institutional holders on record. The largest holder is Aquilo Capital Management, LLC with 3,675,530 shares. Other notable holders include Yoder Stephen S. and Knopf Claude.

PIRS Insider Ownership

Top Holder
Aquilo Capital Management, LLC
3,675,530 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Aquilo Capital Management, Llc 10 Percent Owner 3,675,530 2020-07-22
100%
2 Yoder Stephen S. Chief Executive Officer 634,021 2023-02-28
17%
3 Knopf Claude Chief Business Officer 500,000 2016-11-30
14%
4 Bvf Partners L P/il 10 Percent Owner 314,139 2019-09-10
9%
5 Mousa Ahmed Chief Business Officer 249,080 2023-02-28
7%
6 Kaufmann Hitto Chief Scientific Officer 249,080 2023-02-28
7%
7 Bures Thomas Chief Financial Officer 249,080 2023-02-28
7%
8 Olwill Shane Chief Development Officer 249,080 2023-02-28
7%
9 Reine Allan Chief Financial Officer 162,500 2019-02-28
4%
10 Dellora Investments Lp 10 Percent Owner 141,079 2024-11-18
4%
11 Adar1 Capital Management, Llc 10 Percent Owner 127,331 2024-08-12
3%
12 Matis Louis Chief Development Officer 96,500 2019-02-28
3%
13 Said Maya R. Director 40,000 2023-06-23
1%
14 Richman Michael Director 40,000 2023-06-23
1%
15 Barbier Ann Director 40,000 2023-06-23
1%
16 Sherman Matthew L Director 40,000 2023-06-23
1%
17 Kiener Peter A Director 40,000 2023-06-23
1%
18 Orbimed Advisors Llc 10 Percent Owner 38,870 2018-05-02
1%
19 Prelack Steven Director 20,000 2019-01-29
1%
20 Bizzari Jean-pierre Director 20,000 2020-01-28
1%

No ownership data available for PIRS.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message